药剂师在患者教育和咨询中使用基于视频的资源的使用和有效性:系统审查
Tara Isaacs1, Keshia R De Guzman2, Marissa Ryan1
1School of Pharmacy and Pharmaceutical Sciences, The University of Queensland, Brisbane, Australia; Pharmacy Department, Princess Alexandra Hospital, Brisbane, Australia.
Patient education and counseling
|October 23, 2025
概括
药剂师主导的视频教育改善了患者的健康信息传递. 与传统方法相比,对视频的家庭访问和扩展的干预措施提高了有效性.
科学领域:
- 药房实践 在药房实践中
- 卫生沟通健康沟通
- 医学教育 医学教育
背景情况:
- 患者教育视频在医疗保健中很受欢迎,用于标准化信息.
- 药剂师利用视频资源来补充或提供健康信息.
- 本综述探讨了药剂师使用和基于视频的患者教育的有效性.
研究的目的:
- 系统地审查药剂师如何使用基于视频的资源进行患者教育.
- 评估由药剂师领导的基于视频的患者教育干预措施的有效性.
主要方法:
- 在2023年11月之前,对同行评审文章进行系统审查.
- 使用"药剂师"",患者教育"",视频媒体"等术语搜索了PubMed,EMBASE和CINAHL.
- 包括专注于成年人群的研究,不包括同步视频和社交媒体分析;遵循PRISMA指南.
主要成果:
- 包括37项研究,51%是随机对照试验.
- 视频教育作为辅助 (38%),独立 (35%) 或作为扩展干预 (27%).
- 对视频的家庭访问 (46%) 和扩展的干预措施显示出比常规护理 (21%) 更高的有效性;报告的患者满意度高,知识增加和坚持.
结论:
- 药剂师主导的视频教育与传统方法一样有效,如果不是更有效的话.
- 家庭接入和整合到扩展的干预措施大大提高了效率.
- 基于视频的教育是提高药剂师领导的患者教育成果的宝贵工具.
相关概念视频
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
195
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
195
Nursing Process for Patient and Caregiver Teaching III: Evaluation and Documentation
2.4K
Evaluation of the teaching process enables the nurse to determine if the patient's learning needs were met and if training was effective. If the expected outcomes are not met, the care plan is revised, and additional education or reinforcement is provided. Nurses can ask questions after the session or obtain feedback to assess the patient's understanding of the topic.
Nurses can use several methods to evaluate patient outcomes. For example, oral questions can assess cognitive learning,...
Nurses can use several methods to evaluate patient outcomes. For example, oral questions can assess cognitive learning,...
2.4K
Measurement of Bioavailability: Pharmacodynamic Methods
230
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
230
Drug Dosing: Geriatric Patients
222
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
222
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
249
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
249


